Summary
Thread Guy discusses the recent market highs and the bizarre trend of failing companies pivoting to AI for massive stock pumps. He dives deep into the HIMS trade, exploring the gray market for peptides and the impact of potential deregulation. Additionally, he shares his thoughts on the upcoming SpaceX IPO, warning of a massive retail liquidity drain.
- S&P 500 reaches new all-time highs above 7,000.
- HIMS surges following RFK Jr.'s comments on reclassifying peptides.
- Failing companies like Allbirds and MyAI experience massive pumps after pivoting to AI.
- SpaceX's decision to move up employee vesting schedules ahead of its IPO raises red flags.
- The GLP-1 weight loss drug market is viewed as a structural, long-term growth trend.
- Crypto markets feel narratively weak despite decent price action.